Inhibition of superoxide anion release from human polymorphonuclear leukocytes by N-acetyl-galactosamine and N-acetyl-glucosamine
This study shows that N-acetyl-galactosamine and N-acetyl-glucosamine and diminish the production of superoxide anion from cytochalasin-B treated PMNs stimulated with FMLP. Inhibition ranged from 80.9% to 1.8%. N-acetyl-galactosamine was superior to N-acetyl-glucosamine, but both showed their action in a dose — related fashion. The mannosamine may diminish the superoxide production, but without a statistical significance. Other sugars such as L-fucose, D-fucose and D-glucose failed to induce inhibition of superoxide generation. Previous reports showed that sugars interfere with carbohydrates lectins interaction. This study shows that aminosugars can do more than interfere with carbohydrates-lectin interaction. The mechanism is not completely known yet. The question whether aminosugars affect cell-cell interaction, regulation of respiratory burst, inflammatory mediators functions, or the glucose uptake and utilization needs further study.
Key wordsGalactosamine Glucosamine Polymorphonuclear Leukocyte Enzyme Secretion Superoxide Anion Rheumatoid Arthritis
Unable to display preview. Download preview PDF.
- 1.Harris, E.D. Rheumatoid arthritis. In: Textbook of Rheumatology 3 rd ed. Eds: Kelly, W.N., Harris E.D. Ruddy, S., Sledge, C.B. Philadelphia, W.B. Saunders Company, 1989, 905–942.Google Scholar
- 12.Sharon, N., Lis, H., Lectins: cell-cell agglutinating and sugar specific proteins. Nature 1972, 177, 949.Google Scholar
- 18.Metcalf, J.A. Laboratory Manual of Neutrophil Function. Raven Press, 1986, 111.Google Scholar
- 24.Berman, S.I., Schwarting, G.A., Kolodny, E.H., Babior, B.M. Incorporation of glucosamine by activated human neutrophils. J Lab Clin Med 1980, 96, 893–901.Google Scholar
- 30.Biemond, P., Swaak, A.J.G., Penders, J.M.A., Beindroff, C.M., Koster, J.F. Superoxide production by polymorphonuclear leukocytes in rheumatoid arthritis and osteoarthritis: In vivo inhibition by antirheumatic drug piroxicam due to interference with activation of the NADPH-oxidase. Ann Rheum Dis 1986, 45, 249–55.CrossRefPubMedPubMedCentralGoogle Scholar